Foster Dykema Cabot & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$910K Buy
8,836
+750
+9% +$77.2K 0.11% 40
2023
Q2
$933K Buy
8,086
+454
+6% +$52.4K 0.11% 41
2023
Q1
$812K Buy
7,632
+151
+2% +$16.1K 0.1% 44
2022
Q4
$830K Sell
7,481
-1,062
-12% -$118K 0.12% 43
2022
Q3
$736K Hold
8,543
0.09% 46
2022
Q2
$779K Hold
8,543
0.1% 43
2022
Q1
$701K Buy
8,543
+200
+2% +$16.4K 0.08% 51
2021
Q4
$639K Hold
8,343
0.07% 57
2021
Q3
$627K Sell
8,343
-153
-2% -$11.5K 0.08% 59
2021
Q2
$661K Sell
8,496
-408
-5% -$31.7K 0.08% 57
2021
Q1
$655K Sell
8,904
-13,169
-60% -$969K 0.09% 53
2020
Q4
$1.72M Buy
22,073
+153
+0.7% +$11.9K 0.24% 40
2020
Q3
$1.74M Sell
21,920
-54
-0.2% -$4.27K 0.28% 34
2020
Q2
$1.62M Buy
21,974
+99
+0.5% +$7.3K 0.29% 33
2020
Q1
$1.61M Buy
21,875
+14,986
+218% +$1.1M 0.31% 30
2019
Q4
$598K Hold
6,889
0.08% 58
2019
Q3
$553K Hold
6,889
0.08% 68
2019
Q2
$551K Hold
6,889
0.08% 67
2019
Q1
$547K Buy
6,889
+192
+3% +$15.2K 0.09% 65
2018
Q4
$488K Hold
6,697
0.09% 66
2018
Q3
$453K Hold
6,697
0.07% 73
2018
Q2
$414K Sell
6,697
-68,862
-91% -$4.26M 0.07% 74
2018
Q1
$3.93M Buy
75,559
+3,178
+4% +$165K 0.67% 25
2017
Q4
$3.89M Sell
72,381
-6,056
-8% -$325K 0.65% 25
2017
Q3
$4.79M Sell
78,437
-100
-0.1% -$6.11K 0.84% 21
2017
Q2
$4.8M Sell
78,537
-3,290
-4% -$201K 0.86% 20
2017
Q1
$4.96M Buy
81,827
+1,219
+2% +$73.9K 0.9% 19
2016
Q4
$4.53M Buy
80,608
+287
+0.4% +$16.1K 0.85% 22
2016
Q3
$4.78M Buy
80,321
+571
+0.7% +$34K 1.04% 20
2016
Q2
$4.38M Buy
79,750
+1,499
+2% +$82.4K 1.02% 22
2016
Q1
$3.95M Buy
78,251
+69,561
+800% +$3.51M 0.96% 25
2015
Q4
$438K Sell
8,690
-524
-6% -$26.4K 0.11% 66
2015
Q3
$434K Hold
9,214
0.11% 59
2015
Q2
$501K Sell
9,214
-723
-7% -$39.3K 0.13% 55
2015
Q1
$545K Hold
9,937
0.13% 54
2014
Q4
$538K Hold
9,937
0.13% 55
2014
Q3
$562K Hold
9,937
0.14% 50
2014
Q2
$549K Buy
9,937
+1,142
+13% +$63.1K 0.13% 54
2014
Q1
$476K Hold
8,795
0.12% 54
2013
Q4
$420K Hold
8,795
0.11% 62
2013
Q3
$400K Hold
8,795
0.12% 64
2013
Q2
$390K Buy
+8,795
New +$390K 0.12% 62